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We previously reported  that  6-8-wk old NZB  and NZB/NZW F1  (B/W) 
hybrid mice are relatively resistant to tolerance induction by both ultracentri- 
fuged bovine (BGG)  and human gamma globulin (HGG)  (1).  We also noted 
that immunized NZB and B/W mice made a  higher titered antibody response 
than did NZW, Balb/c, C3H, and C57B1 mice. Similarly, Weir et al. immunized 
NZB mice with soluble bovine serum albumin and found an enhanced antibody 
response and some difficulty in tolerance induction, compared to control CBA 
and C57B1  X  CBA Fi mice (2). In a preliminary report, we showed that 15-17- 
day old NZB  and B/W  mice, in  contrast  to the  6-8-wk old  animals, could 
initially be rendered unresponsive to BGG but that they rapidly lost this toler- 
ance (3). A  series of  experiments was  therefore devised to further investigate 
and extend this latter observation. In this paper, we report the successful in- 
duction of tolerance in older thymectomized and irradiated  mice repopulated 
with lymphoid cells from young animals. 
Materials and Methods 
Animals.--Mice of both sexes, aged 214-6 wk, were obtained from inbred stock colonies 
maintained at the National Institutes of Health  (NIH).  Strains used in these experiments 
were NZB, B/W, C3H, C57B1, and Balb/c. 
6-wk old B/W Fi and Balb/c mice were used in the biofilter experiments. Cell transfer 
studies involved only B/W animals. Recipient B/W mice were 2-3 months of age. Old donor 
mice were 34 months of age, while young donor mice were 12-15 days of age. All animals 
were housed in NIH animal facilities and those which were irradiated received a 10 day course 
of oxytetracycline in their drinking water (0.5 g/liter). 
Antigens.--Pretreatment antigens were bovine gamma globulin Cohn fraction II (Mann 
Research Laboratories, Inc., New York) and egg albumin (Ea) crystallized twice (Worthing- 
ton Biochemical Corp., Freehold, N. J.).  Antibody assays were performed using chromato- 
graphically pure 7S bovine gamma globulin (Mann). This material at a concentration of 10 
mg/ml gives only a single precipitin line after immunoelectrophoresis with rabbit anti whole 
bovine serum (1). 
Tolerance Induetion.--Mice were pretreated with varying doses of ultracentrifuged BGG or 
Ea. Proteins were prepared in a Spinco 40 rotor at 105,000 g for 30 min as previously described 
(1). 
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Single injections: Newborn mice less than 48 hr old received 8.0 mg of soluble BGG given 
into the dorsal subcutaneous tissues in a  0.25 cc volume of normal saline through a  30 gauge 
needle. Young mice 7-9 or 16-18 days of age received  1.6 mg soluble BGG/g of body weight, 
given intraperitoneally. In one experiment with mice aged under 3 wk or over 6 wk, animals 
were  treated with  10.5  or 24.5  mg of ultracentrifuged  BGG.  Soluble  Ea,  8.0-10.0  mg, was 
given to littermates in all experiments as a specificity control. 
Multiple  injections: 3  to 6  day old B/W and C3H mice were given biweekly injections of 
10-15 mg of ultraeentrlfuged BGG or 5 mg of EA intraperitoneally for 5 wk, then challenged 
12 or 28 days later with BGG in Freund's adjuvant. 
In utero injection: Full-term pregnant NZB females carrying B/W hybrid litters were given 
a  single injection of 60 mg of soluble BGG intraperitoneally.  Offspring were challenged at  1 
month of age and bled  1 and 3  months later. 
Challenge.  Young animals were challenged on the 28th day of life. Older animals receiving 
single  injections  of  BGG  were  challenged  12  days  after  pretreatment.  Mice  treated  with 
multiple injections were challenged either 12 or 28 days after the last dose of soluble BGG was 
given. The challenge  regimen was  1.0  mg of  BGG  in  complete  Freund's  adjuvant  (Difco 
Laboratories,  Detroit,  Mich.)  equally distributed over four footpads in a  total volume of 0.2 
CC. 
Antibody Assay.--Mice were regularly bled at 2 wk intervals postchallenge. Antibody titers 
were  assayed by standard  microtiter  hemagglutination methods using tanned formalinized 
sheep cells  (4,  5).  All sera from a  single experiment were studied on the same day.  Known 
positive and negative sera were included with each assay. 
Biofiltration.--Biofiltration  experiments were performed after the method of Mergenhagen 
et al.  (6). Donor B/W and Balb/c mice were given 10 mg of crude BGG or Ea intravenously 
and 16 hr later sacrificed by cervical dislocation. Then 0.2 cc serum containing 1-2 mg BGG 
was given intraperitoneally into recipient animals of both strains. These recipient mice were 
challenged with 2.5 mg of BGG in complete Freund's adjuvant given intraperitoneally 8 days 
later. They were bled at 8, 19, and 34 days postchallenge. 
Serum  Transfer.--2-month  old NZB  or C57B1 mice were used as serum donors.  Animals 
were bled, clot retraction allowed to occur at room temperature, and serum removed and im- 
mediately frozen at --70°C overnight. The next day, 0.25 cc of serum from one or the other 
strain were added to either 10 mg of soluble BGG or EA in 0.25 cc saline and the combination 
was given intravenously to 6-wk old C3H mice. These mice were challenged 12 days later and 
bled at 13 and 40 days. 
Thymectomy.--Thymectomy of 2-3 month old B/W mice was performed under a dissecting 
microscope with the animals under pentobarbital anesthesia (Diabutal). Each mouse received 
0.01 cc/g of body weight of an 8 mg/cc stock pentobarbital  solution intraperitoneally. Thy- 
muses were removed through a  midline sternal incision with a  glass suction catheter and the 
wound closed with Michel wound clips. Examination of random animals (about 15%)  at the 
termination of the studies revealed no thymic remnants. 
Irradiation.--All thymectomized mice were irradiated 5-7 days post-thymectomy in lucite 
boxes holding 7-9 animals/box. Irradiation  was performed with a  double port Westinghouse 
200 Kv,  15 mA machine. Half-value layer (HVL)  =  0.9 mm Cu.  Distance from source was 
54 cm and the rate of dose delivery was 139 R/minute. All mice received 850 R  over 6.11 min. 
Some individual thymus glands from donor animals were irradiated with a  dose of 2000 R 
given at 675 R/min. This dose is adequate to kill all the cells contained in the gland (7). 
Cell Suspensions.--Animals  were  killed  by  cervical  dislocation.  Spleens  were  removed, 
trimmed, and placed  into  cold  Eagle's medium without calcium, magnesium, or antibiotics 
(NIH media unit). They were next teased into small fragments in plastic Petri dishes and the 
dish contents were poured into 40 cc conical glass test tubes. The supernatant cells were sub- P.  J.  STAPLES,  A.  D.  STEINBERG,  AND  N.  TALAL  1225 
sequently aspirated through 20 and 23 gauge needles,  centrifuged at 500 g for 5 min at 10°C, 
and resuspended in appropriate volumes. 
Bone marrow cells were obtained by flushing  Eagle's medium through femurs and tibiae of 
donor mice; then they were handled as were spleen cells. Cell counts were performed in a Levy 
counting chamber using 1% acetic acid diluent. 
Thymus Grafts.--Whole thymus grafts were placed through a small incision into a pocket 
in the axillary subcutaneous tissue of recipient mice. Ether anesthesia was used; a single wound 
clip closed the incision. 
Cell Transfer.--Cell transfer experiments consisted of either spleen cell or whole thymus- 
bone marrow cell transfers. In one study, thymectomized irradiated recipients received 18 >( 
106 spleen cells intravenously from either young (12-15  days) or old (2-3 months) donors. In 
a second study, groups of 10-12  thymectomized irradiated mice were given various combina- 
tions of either young or old whole thymus grafts or bone marrow cells (8)<  106 cells intra- 
venously).  These  combinations were  (a)  young  thymus  and  young  bone marrow;  (b)  old 
thymus and young bone marrow; (c) young thymus and old bone marrow; (d) old thymus and 
old bone marrow; (e) old irradiated (2000 R) thymus and bone marrow. 
On the day after cell transfers, mice were given either 10 mg soluble BGG or 8 mg soluble 
Ea intraperitoneally. Challenge, bleeding schedules,  and  tanned cell hemagglutination assay 
for anti-BGG activity were then carried out as previously described (1). 
RESULTS 
Young and Old Mice.--Young NZB mice developed a transient state of toler- 
ance to BGG, whereas BGG-treated older NZB and B/W mice  made a brisk 
antibody response like that  of  Ea-treated  ]ittermates (Fig. I). Young mice 
given Ea made as much antibody as older mice similarly treated. 
Young Escape.--To determine whether or not  escape from tolerance was 
unique to young NZB mice, a second experiment was performed comparing 
C3H, Balb/c, C57BI, and NZB mice 15-18 days  of age. All mice  received  either 
ultracentrifuged BGG (1.6 mg/g body weight) or Ea (8.0 rag) intraperitoneally 
and were challenged  with BGG in adjuvant at 28 days  of age. 
Only the NZB mice lost their immunological unresponsiveness over time, 
showing a rapid recovery that was maximal at 56 days postchallenge (Fig. 2 
and top of Table I). The C3H, Balb/c, and C57BI  mice continued to be almost 
totally tolerant even  at 160 days of age. 
The data for Ea-treated control animals from the same experiment is shown 
in Fig. 3. The rate of antibody formation in the NZB mice exceeded that in the 
other three strains, and higher titers were attained. The control strains reached 
peak titers at the same  time as the NZB, but the levels  were lower. 
Newborn Escape.--Mice were pretreated with either BGG or Ea, 8  and 5 rag, 
respectively, at less than 48 hr or 7-9 days of age (Table I, bottom).  Challenge 
was  again at  28 days  of life. Pretreatment  of New Zealand mice with BGG  at 
these early ages was not sufficient to maintain a long-term state of tolerance as it 
was in the C3H controls.  By 8 wk postchallenge,  mean titers in NZB and B/W 
mice were greater than half that of Ea-treated  littermates,  whereas they  were 
1/6 in pretreated C3H mice relative to Ea-treated  C3H  controls.  NZB and B/W 1226  INDUCTION  Ot"  IMI~IUNOLOGIC  TOLERANCE 
control animals again had higher antibody titers  than did C3H controls,  as in 
Fig. 3. 
Tolerance Induction In  Utero.--Tolerance  was induced  in B/W  offspring of 
NZB mothers who received BGG during pregnancy (Table II). Pregnant NZB 
females were treated with a single injection of 60 mg of soluble BGG; controls 
were untreated.  Offspring were born 3-4 days later and challenged at 1 month 
of  age.  Those  from  untreated  mothers  made  antibody,  whereas  those  from 
BGG-treated mothers were tolerant.  Tolerant and control mice made compar- 
able amounts of antibody 3 months after challenge. 
Tolerance  Maintenance.--In  an attempt  to induce and  then maintain  toler- 
ance,  BGG was given in multiple  injections  (twice  weekly for 5  wk)  starting 
with mice 3-6 days old. The results  after challenge at  12 or 28 days were the 
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FIG. 1.  Young (16-18 days) or older (over 4 wk) NZB and B/W mice were given 10.5 or 
24.5 mg of soluble BGG and challenged with 1.0 mg of BGG in complete Freund's adjuvant 
12 days later. Each point is the mean titer for 8-14 animals. 
same and are combined in Fig. 4. In contrast to a single injection of BGG, re- 
peated doses of BGG given from birth were successful in inducing and main- 
taining  a  state  of partial  tolerance  to this  antigen.  Mean  titers  in B/W mice 
were less than one-third that of Ea-treated littermates and remained depressed 
throughout the 12 postchallenge wk of study. As in the single injection experi- 
ments  (Figs.  1 and  2),  the  timing of the  (abortive)  escape was again  24  wk 
postchallenge.  The  C3H  mice  showed  an  even  greater  depression  and  made 
virtually no antibody. 
Biofilter Studies.--Of several adult mouse strains studied, Balb/c are difficult 
to render tolerant to ultracentrifuged HGG (1, 8) because they are hyperphago- 
cytic and are immunized by trace amounts of microaggregated protein. Balb/c 
mice  are  also more resistant  to  tolerance  induction  with  BGG.  t  Unlike  New 
1 Staples, P. J., and N. Talal. Unpublished observations. P.  J.  STAPLES~  A.  D.  STEINBERG,  AND  N.  TALAL  1227 
Zealand mice, however, Balb/c can maintain tolerance when it is induced  in 
very young mice (Fig. 2). They also develop tolerance if the aggregates are re- 
moved by  biofiltration  (8).  A  cross-strain  biofiltration  experiment  was  per- 
formed to compare NZB and Balb/c mice. 
Biofiltration of BGG through Balb/c mice prior to injection into other Balb/c 
mice renders the latter recipient animals tolerant (Fig. 5, open squares). How- 
ever, biofiltration of BGG through either Balb/c or NZB mice prior to injection 
into other NZB mice fails to render these latter recipient animals tolerant (Fig. 
5, closed circles). The slope of antibody production  in these  recipient mice was 
the same as in Ea-treated animals (Fig. 5, open circles). 
Thus,  no loss  of  antibody response was  noted when  BGG was  biofiltered 
through either NZB or Balb/c mice and then given back into other NZB ani- 
mals. Since the BGG was sufficiently cleared of aggregates to induce tolerance 
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FIG 2. Tolerance escape curves over a period of time in 3-wk old NZB and control strains 
which were given 8-10 mg soluble BGG at 16--18 days of age. All points represent mean titers 
of 6-13 mice. 
in Balb/c mice, it seems likely that the mechanism responsible for lack of toler- 
ance in NZB mice must be different than the hyperphagocytosis operative in 
the Balb/c strain. 
Serum  Transfer.--This  experiment ruled  out  an NZB  serum  factor  as  re- 
sponsible for the relative resistance  to tolerance. 2-month old NZB and C57B1 
mice were sacrificed, and 0.25  cc of fresh frozen  serum from each  strain  was 
combined with an equivalent volume of either  10 mg of soluble BGG or Ea. 
6-wk  old  C3H  mice received  these  combinations  intravenously,  were  subse- 
quently challenged, and bled. Neither NZB nor C57B1 serum interfered with the 
induction of tolerance in the C3H mice. 
Spleen Cell Transfer.--Old  (2-3 month)  thymectomized and irradiated  (850 
R) B/W recipients were repopulated with either 18 X  106 young (12-15 days) 
or 18  )<  106 old (3-4 months)  spleen cells given intravenously postirradiation. 1228  INDUCTION  OF  IMMUNOLOGIC  TOLERANCE 
TABLE  I 
Loss of Specific  Immunological  Tolerance  to BGG in Neonatal ant Infant NZB and B/W  Mice 
Treatment Group  Mean hemagglutination titer (log..,) to 
BGG  (wk postchallenge)* 
Strain  Age at pre-  Antigen  Injected  No. of  treatment  dose  mice**  2 wk  4 wk  6 wk  8 wk  I0 wk 
mg 
Young Escape: 
NZB  17-18  BGG  12-14  13  0.3  2.2  3.9  --  5.9 
C3H  16-19  "  10-12  10  0.0  0.4  0.5  --  0.6 
Balb/c  15-18  "  10-12  10  0.0  0.1  0.3  --  0.3 
C57B1  16  "  9-12  8  0.0  0.0  0.0  --  0.1 
NZB  17-18  Ea  8  10  3.8  8.1  8.8  --  9.0 
C3H  16-19  "  8  8  2.1  6.0  6.5  --  6.6 
Balb/c  15-18  "  8  10  1.7  4.9  4.7  --  5.3 
C57B1  16  "  8  6  1.6  2.5  2.4  --  3.5 
Newborn  Escape: 
NZB  and B/W  2  BGG  8  7  0.I  2.7  4.6  4.7 
B/W  7-9  "  8  6  2.6  2.3  3.0  4.1 
C3H  2  "  8  10  0.0  0.2  0.3  0.7 
C3H  7  9  "  8  4  0.0  0.2  1.2  1.2 
NZB  and B/W  2  Ea  5  8  4.5  7.1  7.5  7.5 
B/W  7  9  "  5  5  4.0  7.4  7.0  8.0 
C3H  2  "  5  8  4.2  5.8  6.6  6.6 
C3H  7-9  "  5  4  3.6  4.2  6.0  6.2 
m 
* Challenge with  BGG  in  Freund's  adjuvant  at  28  days  of  age. 
:~ Number  of mice surviving at 6-wk bleeding. 
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FIG. 3.  Antibody response curves to challenge with BGG in adjuvant in young (3-wk old) 
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24 hr later,  8-10 mg of soluble BGG or Ea was given intraperitoneally.  Mice 
repopulated  with either young or old spleen  cells  and given Ea had  antibody 
titers  14 days postchallenge which were still rising at 35 days (Fig. 6). Mice re- 
populated with old spleen ceils and given BGG showed an identical  response, 
indicating that tolerance was not induced. On the other hand, old mice repopu- 
lated with young spleen cells and given BGG made no antibody at 14 days, and 
showed escape from tolerance between 21 and 35 days. This is the characteristic 
TABLE II 
Induction of Tolerance by Treatment of Term Pregnant Mothers with 60 Mg BGG 
Treatment of mothers  Titer*  No. of animals 
BGG  0.8  26 
None  4.2  18 
* Hemagglutination  titer of 2-month old NZB/NZW F1 offspring challenged at 1 month 
with BGG in Freund's adjuvant. 
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FIG. 4.  Partial tolerance in B/W mice and complete tolerance in C3H mice treated  from 
birth with 10-15 mg of soluble BGG biweekly. Each point represents 13-15 mice. 
transient tolerance response curve of young animals (Fig. 1), and indicates that 
tolerance was induced in these older mice after repopulation with young spleen 
cells. Moreover, these young spleen cells both develop tolerance and escape from 
tolerance in the recipient mice without benefit of a thymus. 
Thymus-Bone Marrow Transfers.--The thymus has been implicated in toler- 
ance induction  (9) and is necessary in some systems for the escape from the im- 
munologically tolerant state (10). Bone marrow is the site of origin for antibody- 1230  INDUCTION  OF  IMMUNOLOGIC  TOLERANCE 
producing  cells  which  develop  competence  to  certain  antigens  through 
synergistic interaction with the thymus (11-14). 
Fig.  7 and Table III show the results when 2-3 month old thymectomized 
and irradiated B/W mice were given young bone marrow-thymus or old bone 
marrow  thymus combinations. As in the spleen cell transfer system, mice re- 
populated with the old combination and given BGG had an antibody response 
curve similar to Ea-treated age-matched controls. The 4 wk antibody titers for 
both BGG- and Ea-treated mice that were given old cells were lower than those 
customarily seen in intact  older animals, perhaps reflecting a diminished pro- 
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FIG.  5.  Tolerance induction  in Ba]b/c,  but not in NZB  mice, which were given  biofiltered 
BGG.  Bach  point  represents  7-8  mice per  treatment  group.  Antibody  titers  in  NZB  mice 
which received  biofiltered  BGG  were not different from titers in NZB  mice which received 
ultracentrifuged BGG (alone) and results are therefore combined for presentation. 
liferative cell response to  antigen  in  this  artificial system. Nevertheless,  the 
qualitative lack of tolerance induction characteristic  of older NZB  mice was 
clearly present. 
In contrast, mice repopulated with the young combination of thymus-bone 
marrow showed characteristic early tolerance induction followed by rapid loss 
of unresponsiveness (Fig. 7). Control mice treated with Ea made high antibody 
titers. 
Fig. 8 and Table III show the effect of old bone marrow cells in combination 
with a young thymus graft. Tolerance to BGG was not induced in spite of the P.  J.  STAPLES,  A.  D.  STEINBERG,  AND  N.  TALAL  1231 
presence of the young thymus. The slopes of the antibody response curves in the 
four  experimental groups were  parallel.  Antibody  depression  was  about  2~ 
log2 dilutions at 4 wk (3.4/6.2) as compared to 61/~ dilutions (1.4/8.0) at 4 wk in 
mice that were given young marrow-young thymus combinations (Table III). 
Thus bone marrow cells from older B/W mice appear to contain cells resistant 
to immunological tolerance which exert their effect, independent of the age of 
the thymus. 
The effect of young bone marrow cells in combination  with  an  old  intact 
thymus gland is shown in Fig. 9 and Table III. Mice having  this  combination 
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FIO. 6. Tolerance response curves to BGG in thymectomized, irradiated  old  B/W mice 
given either young or old B/W spleen cells. Each point represents the mean value for 7-9 
animals. 
and given BGG responded in the same way as similarly treated mice having 
both  young  marrow  and  young  thymus  glands;  and  tolerance  was  induced. 
Moreover, the antibody response of mice repopulated with young marrow cells 
in combination with old thymus glands was markedly suppressed by BGG, not 
only at 4 wk but also at 6 wk postchallenge (Fig. 9). An identical response was 
seen with an old irradiated thymus gland in combination with young marrow 
cells and BGG (see Table III, last combination). Thus bone marrow cells from 
young B/W mice, like spleen cells of the same age, contain  a  cell population 
which can initially become tolerant to BGG, independent of the thymus. How- 1232  INDUCTION OF  IMMUNOLOGIC  TOLERANCE 
ever, the rapid escape from this tolerance seems to depend on the presence of a 
young thymus.  Old  thymus  tissue,  either  irradiated  or intact,  does not allow 
this early escape to take place. 
DISCUSSION 
These  experiments  confirm our earlier  observations  on immunologic hyper- 
activity and abnormal responses to tolerogens in New Zealand mice (1, 3)  and 
explore the cellular basis for these phenomena.  New Zealand  mice resist the in- 
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FIG. 7. Tolerance response curves to BGG in thymectomized,  irradiated  old B/W mice 
which were given either young thymus-bone marrow or old thymus-bone marrow combina- 
tions. 
duction and maintenance of immunologic tolerance to BGG. Rapid escape from 
tolerance occurs even when BGG is administered in utero or in the first few days 
of life. 
We wish to emphasize,  however,  that the resistance  to tolerance  is relative 
and not absolute. We can maintain partial  tolerance by repeated injections  of 
BGG from birth  (Fig. 4),  and with cyclophosphamide we have induced toler- 
ance in New Zealand mice to  sheep erythrocytes  ~ and to the synthetic RNA 
polyinosinic-polycytidylic acid  (15).  Likewise,  tolerance  to  rabbit  T-globulin 
"~ Jacobs, M., and N. Talal. Unpublished observations. P.  ~[.  STAPLES,  A.  D.  STEINBERG,  AND  N.  TALAL  1233 
can be achieved by repeated  injections or with  cyclophosphamide  (16).  Cerot- 
tiniet  al. have recently  reported  tolerance  to  ultracentrifuged  HGG  in B/W 
mice, but did not comment on the duration of the tolerant state (17). 
Several laboratories  have  observed a premature immunologic maturation and 
augmented immune  reactivity in New Zealand mice that precedes the develop- 
ment  of autoimmunity  (1,  2,  18-20).  Not  all  antigens  are  equally  capable  of 
eliciting this hyperresponse  (17). Nucleic acids in particular are potent antigens 
TABLE III 
Hemagglutination  Titers  (Log2) in  Thymectomized  Irradiated  Adult  B/W  Mice  Repopulated 
with  Young  or Old Bone Marrow  (8 X  106 Cells) or  Thymus  (Whole) 
Wk of  Antigen  Individual titers (Log2)  Mean  Treatment group  Assay  titers 
Young bone marrow  4  BGG  (0, 0, 1, 2, 2, 2, 3)  1.4 
+  Ea  (4, 8, 8, 9, 11)  8.0 
Young thymus  6  BGG  (3, 4, 7, 8, 8)  6.0 
Ea  (7, 9, 9, 9, 10)  9.0 
Old bone marrow  4  BGG  (0, 0, 0, 0, 1, 6, 8, 8)  2.9 
+  Ea  (0, 1, 1, 3, 7, 8, 8, 8)  5.0 
Old thymus  6  BGG  (1, 2, 4, 6, 8, 8, 9, 10)  6.0 
Ea  (6, 7, 7, 9, 11)  8.0 
Old bone marrow  4  BGG  (0, 1, 2, 4, 5, 6, 6)  3.4 
+  Ea  (0, 0, 3, 6, 7, 9, 10, 10, 11)  6.2 
Young thymus  6  BGG  (4, 5, 5, 8, 8, 11)  6.9 
Ea  (6, 9, 10, 10, 10, 10, 11)  9.4 
Young bone marrow  4  BGG  (0, 0, 1, 1, 1, 7)  1.6 
+  Ea  (3, 6, 7, 9, 9, 9)  7.1 
Old thymus  6  BGG  (0, 0, 1, 3, 6)  2.0 
Ea  (8, 9, 9, 9, 10)  9.0 
Young bone marrow  4  B GG  (0, 0, 0, 0, 0, 0, 0, 1)  0.1 
+  Ea  (2, 4, 4, 5, 6, 8, 10)  5.6 
Old irradiated thymus  6  BGG  (0, 1, 2, 2, 3, 6)  2.3 
Ea  (3, 8, 9, 10)  7.5 
in these mice, inducing  or  augmenting  the otherwise spontaneous formation of 
anti-DNA  and anti-RNA  antibodies  and  leading  to  accelerated immune com- 
plex nephritis (21). Both genetic (22) and viral  (23) factors probably play a role 
in these  immunologic  responses  (21). 
Balb/c mice resist tolerance because of a  highly efficient phagocytic mecha- 
nism which can process trace amounts of aggregated protein  (8).  Balb/c mice, 
unlike  New  Zealand  animals,  become  tolerant  to  biofiltered  BGG  (Fig.  5), 
readily maintain  tolerance  (Fig.  2),  and do not show augmented  antibody re- 1234  INDUCTION  OF  IMMUNOLOGIC  TOLERANCE 
sponses (Fig. 3). We suspected that tolerance resistance in New Zealand mice 
was due to a lymphoid abnormality and not to hyperphagocytosis. 
Repopulation  of  older,  thymectomized,  and lethally  irradiated  B/W  mice 
with young, but not old, spleen cells resulted in tolerance followed by escape, 
even though the thymus was absent. In another mouse strain, escape from toler- 
ance  to BGG was dependent upon the thymus (10,  24).  Like old spleen, old 
thymus plus  old bone marrow was resistant  to tolerance  induction,  whereas 
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FIo. 8. Lack of tolerance induction to BGG in thymeetomized, irradiated old B/W mice 
which were given old bone marrow ceils, combined with either young or old thymus grafts. 
young  thymus  plus  young  bone  marrow  showed  transient  tolerance fol- 
lowed by rapid escape. 
Moreover, old bone marrow cells,  whether combined with young or old thy- 
mus,  produced  a  basically adult  B/W  tolerance response curve  (see  Fig.  8). 
This  implies that  resistance to  tolerance  induction  is already present  in  2-3 
month old B/W mice and cannot be reversed by the presence of a  young thy- 
mus.  In this respect,  the bone marrow population  has come to resemble old P.  J.  STAPLES,  A.  D.  STEINBERG,  AND  N.  TALAL  1235 
B/W spleen cells. We cannot determine whether this unusual property repre- 
sents an intrinsic abnormality of bone marrow cells, is the result of cellular in- 
filtration, or an effect of the thymus interacting with the bone marrow in the 
donor prior to transplantation. 
By contrast, young bone marrow cells in combination with either young, old 
unirradiated,  or old irradiated thymus were capable of expressing tolerance in 
the older B/W recipients, unlike old bone marrow cells. This finding again sug- 
gests that  the bone marrow, like  the spleen,  undergoes an age-dependent altera- 
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FIG. 9. Tolerance induction with lack of escape to BGG in thymectomized,  irradiated old 
B/W  mice which were given young bone marrow cells and an old thymus graft. Young 
thymus-young bone marrow response is included for comparison. 
tion in its response to tolerogens. Nevertheless,  the  bone marrow seems to be 
under some thymic regulation since escape from tolerance was delayed if young 
thymus was not present. 
The delay of escape observed with 3-4 month old thymus may reflect an ab- 
normally early loss of thymic regulation o[ lymphoid proliferation. Substitution 
of a known nonfunctioning irradiated old thymus in our studies  produced re- 
sults identical to those seen with old nonirradiated thymus alone, suggesting a 
premature loss of function in the New Zealand thymus. Additional experiments 1236  INDUCTION  OF  IMMUNOLOGIC  TOLERANCE 
with  other antigens and normal mouse strains are necessary before this point 
can be firmly established. 
We  postulate  that  in  New  Zealand  mice,  during  the  process  of  immuno- 
logical maturation, both bone marrow and thymic function become abnormal. 
Spleen and bone marrow cell populations of older animals are resistant to toler- 
ance induced by ultracentrifuged BGG. This defect appears over time and may 
reflect an alteration of lymphoid kinetics or interaction, a change in the mem- 
brane or other component of individual lymphocytes, or some other mechanism. 
Neonatal thymectomy of B/W mice has no effect on the abnormal response to 
BGG  3 and  does  not  ameliorate the  autoimmune  disease  (25).  Prime  atten- 
tion  must  focus,  therefore,  on  the  lymphoid  precursors  present  in  the  bone 
marrow. Playfair reported  that NZB lymphoid precursors transferred  the  in- 
creased  plaque-forming response  to  sheep  erythrocytes  characteristic  of  this 
strain (26). We suggest that both defective lymphoid precursors and abnormal 
thymic regulation are present in New Zealand mice and probably contribute to 
the ultimate emergence of the autoimmune disease. 
SIYMMAR¥ 
Newborn,  7-9  day,  and  16-18  day  old  NZB  and  B/W  mice were,  unlike 
older New Zealand mice, rendered tolerant to single doses of 8-10 mg of soluble 
BGG. After challenge, this tolerance was of short duration and escape occurred 
rapidly. Age-matched and similarly treated C3H, Balb/c and C57B1 mice did 
not escape from tolerance. Partial tolerance could be maintained by repeated 
injections of BGG. 
Biofiltration ruled out hyperphagocytosis as an explanation for this resistance 
to tolerance. Tolerance could be induced in older B/W mice if they were thy- 
mectomized, irradiated, and repopulated with young (12-15  day),  but not old 
(2-3 month), spleen or bone marrow cells.  Old bone marrow cells gave a non- 
tolerant response even when combined with young thymic grafts. Young bone 
marrow gave a  tolerant  response which  was  followed by the  expected rapid 
escape only if a young thymus graft was also present. Escape was retarded if old 
thymus,  or  old  irradiated  thymus,  was  combined with  young  bone marrow. 
These results are best explained by abnormalities of both lymphoid precursors 
and thymic regulation. 
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